Navigation Links
Utilizing Public Relation Strategies During Pharmaceutical Lifecycle Management for Greatest Impact on Brand and Consumer Base
Date:12/12/2011

CHAPEL HILL, N.C., Dec. 12, 2011 /PRNewswire/ -- Public Relations tactics and tools are broad-reaching, affecting millions of consumers when successful. This makes Public Relations a highly leveraged marketing investment, requiring relatively low investment to reach large audiences. More specifically, Public Relations tools can be easily utilized to benefit all phases of the product lifecycle, especially at launch and brand-building years.

However, field research suggests few companies maximize the full potential of PR campaigns throughout the entire product lifecycle – from preparing and launching to growing and extending a brand, according to Best Practices, LLC study, "Using Public Relations to Launch, Grow and Extend Your Brands."

While Public Relations have long been used as a marketing tool by the pharmaceutical and biotechnology industries, its ability to reach consumers has never been greater. This research will help companies take advantage of the many recommendations and actions to better align PR activities and tactics during the different stages of a product's lifecycle.

Public Relations can also help build a bridge from between a first-generation success to a future blockbuster. Field findings revealed that successor product teams generally should commence Public Relations two years prior to the new product's global launch.

Study topics include:

  • Public relations tools and tactics that are most effective at different lifecycle stages
  • The most effective public relations tools and calls-to-action
  • Successful web site resources for consumers
  • Ideal budget ratios and performance measurements
  • Lessons learned and best practices

The full 108-page report contains over 600 benchmark metrics and more than 35 best practices, delivering insights into the most effective Public Relations channels, tactics and calls-to-action for reaching consumers of pharmaceutical products provided by 18 top biopharmaceutical companies.

Specifically, this research document identifies which Public Relations activities most effectively educate and inform consumers at different points in a product's lifecycle. In addition, this study provides leaders with insights into performance measurements for PR campaigns and what web-based resources best engage patients.

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link: http:/www.best-in-class.com/rr1085.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. For more information about Best Practices, LLC visit our Web site at www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
2. New Market Research Report from BioTrends Provides Insight on How Rheumatologists are Utilizing Biologic Agents in the Treatment of Rheumatoid Arthritis
3. nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure
4. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
5. Life Spine® Announces Completion of Surgeries Utilizing OCTAVE™ Posterior Fusion System
6. iCyt Unveils Exciting New Flow Cytometry Reagents Utilizing Innovative Fluorochrome Technology
7. Dry Eye Therapy Utilizing Cationic Novasorb® Technology Available Soon From OCuSOFT®
8. Ambry Genetics Announces Launch of Their CancerArray™ Product and Services Utilizing aCGH Technology
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
11. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... 2016 RnRMarketResearch.com adds "Asthma - ... analysis of Asthma therapy at various stages, therapeutics assessment ... administration (RoA) and molecule type, along with latest updates, ... key players involved in the therapeutic development for Asthma ... Complete report on H1 2016 pipeline review of ...
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for ... Stempeucel® becomes 5th off-the-shelf Stem cell product to be approved by ... Disease (also known as Thromboangiitis Obliterans) is a major unmet medical ... - Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... the European Community & USA ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... ... The Global Wellness Summit (GWS), an annual conference for international ... travel, spa and beauty in Europe. The organization asked its partner experts in Europe ... researchers - to forecast where wellness is headed in Europe. Predictions range from European ...
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... The Orthopaedic ... executive committee members: , David G. Lewallen, MD, began his term as president ... president. Michael L. Parks, MD, is OREF’s new president-elect. Richard F. Kyle, MD, will ...
(Date:5/31/2016)... , ... May 31, 2016 , ... In a recent ... Feiner and broadcast on New Rochelle, NY-based WVOX (1460 AM), leading medical ... what she calls the country’s “modern medical money maelstrom.” , During the interview ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet a growing demand ... industry, The University of Scranton is adding a Certificate in Health Informatics to ... in rapidly growing field of healthcare information. , Healthcare organizations are under ...
(Date:5/30/2016)... , ... May 30, 2016 , ... ... use inside of FCPX," said Christina Austin - CEO of Pixel Film Studios. ... use within Final Cut Pro X. Choose from abstract transitions to more simple ...
Breaking Medicine News(10 mins):